Breaking News, Promotions & Moves

Pharma Tech Industries Appoints Interim CEO

VanVliet joins the company with more than 20 years of experience serving in executive roles

By: Kristin Brooks

Managing Editor, Contract Pharma

David VanVliet has been appointed interim chief executive officer, Pharma Tech Industries. Mr. VanVliet will assume overall leadership of the company, while industry veteran Tee Noland will transition to a new role as Pharma Tech’s chairman of the board.

Mr. VanVliet joins the company with more than 20 years of experience serving in executive roles spanning the healthcare and pharmaceutical sectors.

Most recently, he served as president and chief executive officer of Angelica, Inc., a supplier to thousands of hospitals, clinics and long-term care facilities. Mr. VanVliet successfully guided the company’s 4,000 employees and 26 production centers. He also has held leadership roles at companies including KV Pharmaceutical, Procter & Gamble, and Nabisco, Inc.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters